home / stock / ngvt / ngvt articles
Shares of Vaxxinity, Inc. (NASDAQ:VAXX) fell sharply during Monday's session after the company announced its intention to voluntarily delist a...
As of Dec. 26, 2023, four stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in thei...
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicate...
News, Short Squeeze, Breakout and More Instantly...
Ingevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2024 earnings after the stock market close on Wednesday, July 31, 2024. The company will host a live webcast on Thursday, August 1, at 11:00 a.m. (Eastern) to discuss second-quarter 2024 fiscal results. T...
Ingevity Corporation (NYSE:NGVT) today announced the appointment of Ryan C. Fisher as senior vice president, general counsel and secretary and Terry Dyer as senior vice president and chief human resources officer. “We are excited to add Ryan and Terry to our executive leadership team,&...
2024-07-10 10:00:09 ET John McNulty from BMO Capital issued a price target of $45.00 for NGVT on 2024-07-10 08:45:00. The adjusted price target was set to $45.00. At the time of the announcement, NGVT was trading at $40.62. The overall price target consensus is at $59.00...